In this context, GSTM3 up-regulation occurs via recruiting and binding SP1, EP 300, and AP-1 transcription factors to its promoter by ER (Estrogen receptor) intermediation in ER-positive breast cancer (Bièche et al., 2004[4]; Lin et al., 2018[40]). The gene discussed is GSTM3; the disease is breast cancer.